Member Info for lordloadsoflolly

Morri940 - see link below. The "new optimised international Phase III trial in lupus patients (was) targeted to commence in 2020".

Meanwhile, here we are 5 years later, having been promised regular comms updates from Tim McDim. Yet not a dicky bird.

Plenty of RNSs about all the dilutive refinancing though. So that's alright then - cos Tigger says so.

www.immupharma.co.uk/immupharma-avion-pharmaceuticals-sign-exclusive-licence/

Special mention to Tigger. He promised us an RNS this week and that's EXACTLY what we got.

Wait though, this doesn't quite read like the news he & his city chums promised us just days ago (nudgy nudgy, tinky winky, share price sinky).

Monteacute - we’ll make a Tigger of you yet. Just remember to add the disclaimer at the end though:

"THE ABOVE IS NOT ATTENDED AS FINANCIAL ADVICE".

So I guess now the only questions left are:

Will it be Moderna or Roche?

And will it be next Monday, Tuesday or only when there’s an “r” in the month with a cold northerly blowing? (nudgy nudgy northy windy).

Tigger - "THE ABOVE IS NOT ATTENDED AS FINANCIAL ADVICE". Oh dear, you really are a one.

And now you're even resorting to posting in CAPITAL LETTERS. Reminds me of Trump & his giant Sharpie pen.

Do you have a spray tan too?

Nova - yes it’s obvious they need to generate annual sales far closer to £200m to generate sustainable profits.

There’s also a cashflow timing element, as new orders require significant upfront expenditure. Which is why staged payments seem an obvious pre-condition of any new sales deals.

A slashing of overheads also wouldn’t go amiss. Though maybe not quite Musk-style.

You can’t read anything into the lack of a recent placing.

With the share price currently above 2.6p, IMM will automatically qualify for higher monthly payments from Lanstead. So it may be that this alone is what’s keeping them afloat .

In which case, the SP needs to remain around its current level if a placing is to be avoided.

The way I read this proposal, there IS a potential dilution effect AND a form of interest payable:

“The Noteholders shall have the right to convert some or all of the principal into ordinary shares at a conversion price of 15 pence per share (the "Conversion Price") at any time prior to maturity of the Loan Notes”.

“the Noteholders may also elect for any or all of their Loan Notes (to) be cash-settled. In such circumstances, the Company shall pay the Noteholder:

· the nominal value of the Loan Notes, plus

· a redemption premium equal to the amount by which the Conversion Price is exceeded by the highest daily VWAP of the Company's ordinary shares over the period of seven trading days prior to the notice of Conversion, multiplied by the number of the Company's ordinary shares that the Noteholder would have received had it proceeded with Conversion.”

Also, it appears to have cost almost £3.2m to raise £18m:

“convertible loan notes in an aggregate principal amount of £21,176,470.59 at 85% of the face value, to raise aggregate subscription proceeds of £18 million.”

Whilst market reaction to this may remain positive, I don’t think you can judge it either way from the first few minutes after opening.

Whilst funding security is crucial, you have to ask why IQE even needs another £18m for short term working capital? Can’t it structure staged payments from its customers to cover its day to day running & stock costs?

Hmmm, not so sure about that, Marty130.

Two things strike me about this morning’s RNS:

1) IQE finally admits it’s not “THE leading supplier of compound semiconductor wafer products and advanced material solutions”, despite claiming this accolade for years. Instead, it’s now just “one of the leading global suppliers”.

2) Loan note financing is essential for IQE to remain solvent short term. So if this resolution isn’t approved by shareholders (which I imagine it will be) the company would effectively go bust:

“ The directors … believe that successful completion of the Proposed Transaction is required to maintain sufficient short-term liquidity whilst the Company completes the ongoing strategic review.”

Max19 - who knows, you may be right.

But what significant IQE developments have driven this SP rise?

I can’t really point to any yet. I guess shares may have changed hands between IIs. Or shorts below the reportable threshold may have been closed.

But that’s largely speculation, so you wonder just how sustainable this re-rate will be.

Perhaps investors are anticipating significant value being unlocked from the Taiwanese subsidiary. Or maybe IQE was just oversold around the 10p mark.

Either way, I think it’ll take more concrete news to maintain this momentum, or even to sustain the current SP level.

Goldgirl - sorry but that explanation doesn’t “nail it” at all.

It’s the radio silence for well over a year that investors will be concerned about. At any stage, Tim could easily have said preparations for the revised P3 trial were progressing smoothly. He could also have given an approx. estimated start date without jeopardising anything.

So the question remains. Why hasn’t he?

Spantrout - this does seem different from previous pumps & dumps, in that the SP has held up for some considerable time since.

But why IMM’s prolonged radio silence on the next P3 trial? I don’t think any “novel insight” explains the delay sufficiently, do you?

Rookie1 - AIM’s crammed with CEOs who’ve promised the earth, only to fall at the first (or at best, the last) fence.

And for some bizarre reason, over the years Tim does seem to have been Teflon coated.

Monteacute - agreed; many rampers & derampers are just childish & annoying. But Tigger’s in a total class of his own. Even if our investment ultimately IMMplodes, at least many will go down smiling with Tigger at the helm. And for the rest, there’s always the filter button.

Tigger - TBH it's hard to tell if you're a "genuine soul" or just an ar soul.

But you DO make us all laugh. So even if this week comes & goes without the much-heralded "nudge nudge", PLEASE carry on with your posts. It's almost been worth investing here just to read them.

You quite okay there Tigger?

I reckon you’ve had more than eggs & avocado for brekky. Perhaps a side of magic mushrooms?

Anyhow, you’ll no doubt be delighted to hear I am already a LTH here. Though, sadly, my decision wasn’t HUGELY influenced by your many nudgy nudgies.

Think you’ll find it’s ZaK Mir (whose share tips are about as reliable as a Reliant Robin trying to negotiate a hair pin bend on the brow of an icy hill in winter).

Jam96p - personally I WOULD want an RNS, as it’s infinitely preferable to the vague, constantly timeline-changing reassurances of some Disney character aka Tigger.

Oh dear. Another sense of humour bites the dust.

Oh Tigger, not sure I’d be quite so candid about those “keeper” investments of yours.

Particularly PPP, which as you say, has been suspended (since early Aug 24?) .

Have you read its most recent RNSs? Sounds to me like PPP might be RIP.

Still, if your city chums have told you everything’s OK there (nudgy nudgy tinky winky), then I’m sure it’ll be just fine.

Looking forward to IMM multibagging on Monday. Or is it just sometime next week now? You seem to keep moving the goalposts, which is slightly disturbing as I sold all my racehorses on Friday putting the lot on Monday’s IMM 7.00am Cheltenham Gold Cup.